Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

BACKGROUND: Ascorbic acid reduced the severity of neuropathy in transgenic mice overexpressing peripheral myelin protein 22 (PMP22), a model of Charcot–Marie–Tooth disease type 1A (CMT1A) associated with the PMP22 duplication. However, in three 1-year trials, ascorbic acid had no benefit in human be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pareyson, Davide, Reilly, Mary M, Schenone, Angelo, Fabrizi, Gian Maria, Cavallaro, Tiziana, Santoro, Lucio, Vita, Giuseppe, Quattrone, Aldo, Padua, Luca, Gemignani, Franco, Visioli, Francesco, Laurà, Matilde, Radice, Davide, Calabrese, Daniela, Hughes, Richard AC, Solari, Alessandra
Formato: Artigo
Idioma:Inglês
Publicado em: Lancet Pub. Group 2011
Assuntos:
Fast track — Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3154498/
https://ncbi.nlm.nih.gov/pubmed/21393063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(11)70025-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados